Collegium Pharmaceutical, Inc. (COLL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.47B |
| Enterprise Value | 2.16B |
| P/E Ratio | 14.11 |
| PEG Ratio | 0.2 |
| Price/Sales Ratio | 1.36 |
| Price/Book Ratio | 3.44 |
| Enterprise/Revenue | 2.04 |
| Enterprise/EBITDA | 2.66 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.09 |
| Operating Margin | 0.24 |
| Return On Assets | 0.05 |
| Return On Equity | 0.27 |
| Revenue | 780.57M |
| Revenue/Share | 24.82 |
| Gross Profit | 463.26M |
| EBITDA | 401.01M |
| Net Income | 62.87M |
| Diluted EPS | 1.73 |
| Total Cash | 421.75M |
| Total Cash/Share | 13.14 |
| Total Debt | 808.06M |
| Total Debt/Equity | 2.59 |
| Current Ratio | 1.71 |
| Book Value Per Share | 9.74 |
| 52-Week Change | 11.95 |
| 52-Week High | 50.79 |
| 52-Week Low | 29.19 |
| Moving Average 50 Days | 34.1 |
| Moving Average 200 Days | 39.27 |
| Average Volume | 467,854 |
| Shares Outstanding | 32.43M |
| % Held by Institutions | 119.75 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |